Hydromed

Hydrochlorothiazide, the active ingredient in Hydromed, is a thiazide diuretic presented as an oral tablet for oral use. It helps lower blood pressure and reduces excess fluid in conditions such as hypertension, heart‑failure‑related edema, and certain renal disorders.

GNH USA supplies Hydromed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Hydrochlorothiazide acts on the renal tubular system to manage fluid‑related conditions and high blood pressure. - Hypertension: lowers systolic and diastolic pressure by promoting sodium and water excretion. - Edema associated with heart failure: reduces peripheral and pulmonary fluid accumulation. - Renal disorders with fluid overload: assists in controlling volume status in chronic kidney disease.

Hydrochlorothiazide may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Increased urination: more frequent need to void. - Dizziness or light‑headedness, especially on standing. - Electrolyte disturbances such as low potassium or sodium. - Photosensitivity: heightened skin reaction to sunlight.

Serious or Rare Side Effects: - Severe allergic reactions, including rash, itching, swelling, or anaphylaxis. - Acute gout attacks due to elevated uric acid levels. - Pancreatitis or severe abdominal pain. - Blood dyscrasias such as leukopenia or thrombocytopenia.

Before initiating therapy, clinicians should consider several safety measures. - Electrolyte monitoring: check serum potassium, sodium, and magnesium regularly. - Renal function assessment: evaluate creatinine clearance to adjust dosing. - Diabetes caution: monitor blood glucose as thiazides may impair glucose tolerance. - Hepatic disease: use with caution in patients with severe liver impairment. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Hydrochlorothiazide can alter the effects of several other medicines.

Major Interactions (Avoid): - Lithium: increased risk of lithium toxicity. - Cyclosporine: heightened nephrotoxicity. - Digoxin: elevated serum digoxin levels.

Moderate Interactions (Monitor Closely): - Antidiabetic agents: possible reduction in blood‑glucose control. - ACE inhibitors or ARBs: may enhance potassium loss. - NSAIDs: can diminish diuretic efficacy and affect renal function. - Corticosteroids: may increase sodium retention counteracting the diuretic effect.